80 related articles for article (PubMed ID: 19958226)
21. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
Berstein LM; Yue W; Wang JP; Santen RJ
Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
[TBL] [Abstract][Full Text] [Related]
22. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance.
Johnston SR; Lu B; Scott GK; Kushner PJ; Smith IE; Dowsett M; Benz CC
Clin Cancer Res; 1999 Feb; 5(2):251-6. PubMed ID: 10037172
[TBL] [Abstract][Full Text] [Related]
23. [Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation].
Wang Y; Guo XQ; Niu XL; Wu J; Zhu YQ; Mao LQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):21-4. PubMed ID: 20056081
[TBL] [Abstract][Full Text] [Related]
24. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
25. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
27. Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.
Britton DJ; Hutcheson IR; Knowlden JM; Barrow D; Giles M; McClelland RA; Gee JM; Nicholson RI
Breast Cancer Res Treat; 2006 Mar; 96(2):131-46. PubMed ID: 16261397
[TBL] [Abstract][Full Text] [Related]
28. [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29].
Fang YJ; Wang GQ; Lu ZH; Zhang LY; Pan ZZ; Zhou ZW; Wan DS
Ai Zheng; 2008 Nov; 27(11):1172-6. PubMed ID: 19000448
[TBL] [Abstract][Full Text] [Related]
29. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM
Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
[TBL] [Abstract][Full Text] [Related]
31. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
32. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].
Hoeller U; Borgmann K; Feyer P; Souchon R;
Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084
[TBL] [Abstract][Full Text] [Related]
33. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
34. Experimental endocrinotherapy with tamoxifen of human ovarian dysgerminoma transplanted into nude mice.
Isonishi S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2185-92. PubMed ID: 3429992
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
36. Single-walled carbon nanotubes mediated targeted tamoxifen delivery system using aspargine-glycine-arginine peptide.
Chen C; Hou L; Zhang H; Zhu L; Zhang H; Zhang C; Shi J; Wang L; Jia X; Zhang Z
J Drug Target; 2013 Nov; 21(9):809-21. PubMed ID: 24024582
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures.
Stackievicz R; Drucker L; Radnay J; Beyth Y; Yarkoni S; Cohen I
Clin Cancer Res; 2001 Feb; 7(2):415-20. PubMed ID: 11234898
[TBL] [Abstract][Full Text] [Related]
38. Radiolabeled oligosaccharides nanoprobes for infection imaging.
Shukla J; Arora G; Kotwal PP; Kumar R; Malhotra A; Bandopadhyaya GP
Hell J Nucl Med; 2010; 13(3):218-23. PubMed ID: 21193873
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
Fan P; Wang J; Santen RJ; Yue W
Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl radicals under the effect of tamoxifen-ferrocene conjugate.
Wlassoff WA; Albright CD; Sivashinski MS; Ivanova A; Appelbaum JG; Salganik RI
J Pharm Pharmacol; 2007 Nov; 59(11):1549-53. PubMed ID: 17976267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
